• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Shaji ???





















































I'm on the oncology side of Eisai. This business is going away fast. New products in2 of the top indications, breast and HCC. Also, Merck owns 51% of Lenvima. Shari either left because she knows something is coming and its a good time to get out, she was forced out or, she has another job. Look at the turn over on this side, it's crazy and, most people will not come over here to work. Nice people but, it's not a career.
 
















Lots of sexist comments.... she outworked everyone in front of her, and made her way up the ladder... good leader ... lots of jealous men out there looking to trash a woman who outworked them